IMMUNE PHARMACEUTICALS INC: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $0
- Net Income/Loss (FY2017)
- -$17.9M
- Total Assets (FY2017)
- $28.6M
- Cash Flows from Operating Activities (FY2017)
- -$11.6M
Source: IMMUNE PHARMACEUTICALS INC 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
